1.Microsurgical approaches to the treatment of obstructive azoospermia.
Philip S LI ; Qiang DONG ; Marc GOLDSTEIN
National Journal of Andrology 2004;10(9):643-650
In the past 5 to 10 years, very few fields in modern medicine have changed so dramatically as reproductive medicine, especially for the treatment of male infertility. Advances have been made in intracytoplasmic sperm injection (ICSI), refined microsurgical reconstructive techniques (vasovasostomy and vasoepididymostomy), and microsurgical techniques of surgical sperm retrieval from the epididymis and testis. All men with epididymal obstruction (obstructive azoospermia) now have the opportunity to father their own biological children. In this article, the authors reviewed the most updated microsurgical vasovasostomy, vasoepididymostomy techniques and surgical indications as well as the key factors for successful microsurgical treatment. They also predicted the future directions and discussed the advantages of microsurgical techniques, emphasized the significant roles of microsurgical training for urological doctors to treat male infertility.
Epididymis
;
surgery
;
Fertilization in Vitro
;
Humans
;
Male
;
Microsurgery
;
Oligospermia
;
surgery
;
Sperm Injections, Intracytoplasmic
;
Vasovasostomy
;
methods
2.Recent research on vasectomy techniques.
Asian Journal of Andrology 2003;5(3):227-230
Vasectomy is a commonly used, highly effective method for the control of fertility in the human male. It is almost always performed as an outpatient procedure, is safer than tubal occlusion and has few side effects. The number of people relying on vasectomy as a method of contraception varies widely from country to country. Though vasectomy is highly effective, failures may occur due to re-canalization of the vas, surgical error, anatomical variants or failure of contraception during the post-operative waiting period. One of the disadvantages of this technique is that sperm are present in the posterior end of the vas following surgery and hence patients have to use alternative methods of contraception for a waiting period of 12 weeks to 15 weeks before relying on a vasectomy for contraception. This review summarizes recent research on vasectomy conducted by Family Health International, USA.
Adult
;
Cautery
;
Humans
;
Ligation
;
Male
;
Nepal
;
Oligospermia
;
Sperm Count
;
Vas Deferens
;
surgery
;
Vasectomy
;
methods
3.Subinguinal microsurgical varicocelectomy is safe and effective in a solitary testicle.
Piotr DOBRONSKI ; Karolina DOBRONSKA ; Lukasz KUPIS ; Piotr RADZISZEWSKI
Asian Journal of Andrology 2020;22(1):120-121
Adult
;
Asthenozoospermia/complications*
;
Azoospermia/surgery*
;
Humans
;
Male
;
Microsurgery/methods*
;
Oligospermia/complications*
;
Orchiectomy
;
Seminoma/surgery*
;
Testicular Neoplasms/surgery*
;
Ultrasonography, Doppler, Color/methods*
;
Urologic Surgical Procedures, Male/methods*
;
Varicocele/surgery*
4.Surgical therapy for azoospermia with ejaculatory duct obstruction.
Chun-hua DENG ; Shao-peng QIU ; Xiang-zhou SUN ; Hai-bin GUO ; Rong-pei WU
Chinese Journal of Surgery 2005;43(22):1464-1466
OBJECTIVETo investigate the effect of transurethral resection of ejaculatory ducts (TURED) for azoospermia with ejaculatory duct obstruction (EDO).
METHODSFrom June 2003 to December 2004, 20 azoospermia with EDO were diagnosed, diagnostic criteria included a history, physical examination, semen analyses, semen fructose measurement, endocrine assessment, testicular biopsy and transrectal ultrasonography (TRUS); All 20 cases were treated by TURED. Fifteen of them were followed up more than 3 months after the treatment. The semen samples of them were analysed at 3-month intervals in post-therapy.
RESULTSSemen analyses in all 20 cases showed the typical characteristics of EDO, low semen volume (0.4-1.6 ml), azoospermia, low pH, absent or low semen fructose. TRUS showed the main etiology factor of EDO was a midline cyst in 11, lateral cystic lesions in 2, the remaining 7 cases had dilated ejaculatory duct with or without dilated seminal vesicles. Among 15 cases followed up more than 3 months after TURED, 10/15 (67%) had an improvement in semen parameters and 3/15 (20%) had pregnancies. Semen analyses had not been done in anther 5 cases.
CONCLUSIONTransurethral resection of ejaculatory ducts may be a safe and effective method for the treatment of azoospermia with EDO.
Adult ; Azoospermia ; diagnosis ; surgery ; Ejaculatory Ducts ; diagnostic imaging ; pathology ; surgery ; Electrosurgery ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Oligospermia ; diagnosis ; Ultrasonography
5.Clinical application of cross microsurgical vasovasostomy in scrotum for atypical obstructive azoospermia.
Zhong-Yan LIANG ; Feng-Bin ZHANG ; Le-Jun LI ; Jing-Ping LI ; Jing-Gen WU ; Chong CHEN ; Yi-Min ZHU
Journal of Zhejiang University. Science. B 2019;20(3):282-286
Seminal duct obstruction may result in obstructive azoospermia (OA) and severe oligoasthenoteratozoospermia (OAT) (<0.5 million/mL) (Nordhoff et al., 2015). Cases of partial OA and OAT can be treated effectively by microsurgical anastomosis (Goldstein and Kim, 2013) to obtain successful surgical reversal. However, microsurgical vasovasostomy (VV) (Dickey et al., 2015) and vasoepididymostomy (VE) (Peng et al., 2017) are not suitable for patients with atypical OA and poor epididymis conditions or unpredictable obstruction of the distal vas deferens. For those patients, cross anastomosis may be applied instead of routine VE or VV. A single-center, retrospective, comparison study was conducted, which assessed the usefulness of the cross VV (CVV) in the scrotum for indication and efficacy. A total of 77 cases with OA or OAT were included, and 20 cases implemented cross anastomosis, including unilateral CVV (UCVV) in 4 cases, unilateral VE plus CVV (UVE+CVV) in 11 cases, and unilateral VV-based CVV (UVV+CVV) in 5 cases. The other 57 cases received no cross-matching anastomosis. The patency and natural pregnancy rates in one year were 75.0% and 50.0%, respectively, in the UCVV group; 54.5% and 27.3%, respectively, in the UVE+CVV group; and 60.0% and 40.0%, respectively, in the UVV+CVV group. The CVV in the scrotum in the selected patients with OA and severe OAT could yield good results. We regard the CVV in the scrotum as an efficacious operation with a lower risk of injury in cases of atypical OA.
Adult
;
Anastomosis, Surgical
;
Azoospermia/surgery*
;
Epididymis/pathology*
;
Female
;
Humans
;
Infertility/surgery*
;
Male
;
Oligospermia/surgery*
;
Pregnancy
;
Pregnancy Rate
;
Retrospective Studies
;
Scrotum/surgery*
;
Treatment Outcome
;
Vas Deferens
;
Vasovasostomy/methods*
;
Young Adult
6.Integrated treatment for azoospermia caused by radiotherapy after surgical treatment of spermatocytoma: a case report.
Bao-fang JIN ; Xiao-yu YANG ; Jia-yin LIU ; Yu-feng HUANG ; Xiu-lai WANG ; Fu-song XU
National Journal of Andrology 2006;12(9):836-838
OBJECTIVETo investigate a therapeutic method for male infertility caused by radiotherapy after surgical treatment of spermatocytoma.
METHODSA case of azoospermia caused by radiotherapy after surgical treatment of spermatocytoma was reported and the Chinese medicine Jiaweishuiluerxiandan was used as a major therapy for 3 years.
RESULTSThe patient's health condition was improved dramatically two years after being treated by the Chinese medicine but no sperm was found in his semen. However, three years after the treatment, his spermatozoon density was recovered from zero to 2.0 x 10(6)/ml with normal morphology. His sperm was subsequently used for intracytoplasmic sperm injection, which made his spouse pregnant successfully, and an healthy male infant was born by caesarean birth.
CONCLUSIONChinese medicine is a successful try at treating male infertility caused by radiotherapy after surgical treatment of spermatocytoma. For those who have failed to get their sperm frozen before surgery, Chinese medicine is a choice for remediation.
Adult ; Drugs, Chinese Herbal ; therapeutic use ; Female ; Humans ; Male ; Oligospermia ; drug therapy ; etiology ; Phytotherapy ; Pregnancy ; Radiotherapy ; adverse effects ; Seminoma ; radiotherapy ; surgery ; Sperm Count ; Testicular Neoplasms ; radiotherapy ; surgery ; Treatment Outcome
7.Intratunical bupivacaine and methylprednisolone instillation for scrotal pain after testicular sperm retrieval procedures.
Gul K TALU ; Tibet ERDOGRU ; Tansel KAPLANCAN ; Mustafa BAHCECI
Asian Journal of Andrology 2003;5(1):65-67
AIMTo investigate the effect of intratunical instillation of bupivacaine and methylprednisolone for scrotal pain, swelling and peritesticular fibrosis due to testicular sperm retrieval procedures.
METHODSA total of 65 patients were randomly divided into two groups. In the instillation group (GI), 34 patients were administered 2.5 mL of 0.5 % bupivacaine combined with 10 mg/ml methylprednisolone before closure of the tunica vaginalis. In the control group (GC), 31 patients only received analgesics postoperatively by intramuscular route. The pain (by visual analogue scale, VAS) and duration of pain-free period after surgery between the two groups were evaluated at 2 and 4 h and at days 2 and 7 postoperatively.
RESULTSThe mean pain scores were significantly lower in the GI than in the GC group at 2 and 4 h after surgery (P<0.05 and P<0.01, respectively). The mean duration of pain free interval after the procedure was 47.8 +/-16.9 (12-72) h in GI, which was significantly longer than that in GC [(9.9 +/-3.6; 4-20) h]. Besides, in the GI, 29 % of patients were completely free from pain and 67 % had no scrotal swelling, but in the GC, all the patients required additional NSAID injection due to pain and only 3 % had no scrotal swelling.
CONCLUSIONThis study confirms that direct intratunical instillation of bupivacaine and methylprednisolone around the testis reduces the postoperative pain, scrotal swelling and peritesticular fibrosis.
Adult ; Anesthetics, Local ; administration & dosage ; Anti-Inflammatory Agents ; administration & dosage ; Bupivacaine ; administration & dosage ; Humans ; Male ; Methylprednisolone ; administration & dosage ; Oligospermia ; surgery ; Pain, Postoperative ; drug therapy ; Scrotum ; Spermatozoa ; cytology ; Treatment Outcome